Daniël Jan Ellens
President chez Elkerim GmbH
Profil
Daan Ellens serves on the supervisory board of Zealand (DK).
He was, until recently, chief executive officer of Rhein Biotech, a global biotechnology group, which develops, produces and markets vaccines and therapeutic compounds based on its platform technologies.
As the CEO, Dr. Ellens restructured Rhein Biotech from a German contract research organization into a rapidly growing worldwide operating biotech group, listed at the Neuer Markt in Frankfurt .
In 2002, he merged Rhein Biotech with Berna, based in Switzerland , thus positioning the combined entity as the world’s number one pure-play vaccine company.
He was instrumental in developing the company until where it is today.
Daan Ellens received his PhD in Molecular Biology of the University Utrecht in 1974 and an MBA degree from the Technical University Eindhoven and the University of Tilburg in1992.
Daan’s extensive and successful track record as one of the most successful European biotech entrepreneurs adds significant value to the LSP team and investment process.
Dr. Ellens is venture partner at Life Sciences Partners, Amsterdam.
Postes actifs de Daniël Jan Ellens
| Sociétés | Poste | Début |
|---|---|---|
Elkerim GmbH
 Elkerim GmbH Real Estate DevelopmentFinance Elkerim GmbH provides biotechnology, art, real estate advisory and brokerage, and financing services. The private company is based in Schwarzenburg, Switzerland. | President | 02/12/2010 |
Anciens postes connus de Daniël Jan Ellens
| Sociétés | Poste | Fin |
|---|---|---|
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Private Equity Investor | 31/03/2015 |
Rhein Biotech NV
 Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands. | Président | - |
Janssen Vaccines Corp.
 Janssen Vaccines Corp. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Vaccines Corp. is a South Korean company that manufactures finished medicaments. The company is based in Yongin, South Korea. Janssen Vaccines was acquired by Rhein Biotech NV from Green Cross Corp. on January 03, 2005. | Président | 01/01/2006 |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Directeur des opérations | 01/12/2004 |
Janssen Vaccines Corp.
Janssen Vaccines Corp. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Vaccines Corp. is a South Korean company that manufactures finished medicaments. The company is based in Yongin, South Korea. Janssen Vaccines was acquired by Rhein Biotech NV from Green Cross Corp. on January 03, 2005. | Directeur des opérations | 01/12/2001 |
Formation de Daniël Jan Ellens
| Technische Universiteit Eindhoven | Masters Business Admin |
| University of Utrecht | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ATON | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Entreprise privées | 9 |
|---|---|
Berna Biotech AG
Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
Rhein Biotech NV
Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands. | Commercial Services |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Finance |
Janssen Vaccines Corp.
Janssen Vaccines Corp. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Vaccines Corp. is a South Korean company that manufactures finished medicaments. The company is based in Yongin, South Korea. Janssen Vaccines was acquired by Rhein Biotech NV from Green Cross Corp. on January 03, 2005. | Health Technology |
Kreatech Biotechnology BV
 Kreatech Biotechnology BV Medical/Nursing ServicesHealth Services Kreatech Biotechnology BV provides diagnostics detection products. It develops tools for labeling and detection of DNA, RNA, and proteins molecules. The company's products are used in the areas of Oncology, Haematology, and Pre-natal diagnostics. It offers services to the drug discovery, pharmaceutical, diagnostics, and life science companies. Kreatech Biotechnology was founded by Volkers Herman in 1990 and is headquartered in Amsterdam, the Netherlands. | Health Services |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Kreatech Holding BV
 Kreatech Holding BV Medical/Nursing ServicesHealth Services Kreatech Holding BV provides detection products. Its products are used for used for diagnostic and research applications in the life sciences and healthcare industry. The company was founded in 1990 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Elkerim GmbH
Elkerim GmbH Real Estate DevelopmentFinance Elkerim GmbH provides biotechnology, art, real estate advisory and brokerage, and financing services. The private company is based in Schwarzenburg, Switzerland. | Finance |
